The usual PBM strategy cuts an independent pharmacy's share of the prescription revenue to just 3 cents per pill dispensed, ...

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates appetite and digestion. The medications control blood sugar and help people ...

Medisca to pay $21.75 million to settle case alleging false and inflated ingredient prices, accused of inflating prices for resveratrol and mometasone furoate.

Amid a growing cavalcade of Biden/Harris administrative agency miscues and misdeeds, a letter from Republican Senators Tom ...

Ohioans must recognize the threat that vertically-integrated insurance conglomerates pose to our health and pocketbooks.

The rules are a game-changer that supporters say will require companies to be more transparent and take the burden off regulators in trying to prevent illegal mergers and acquisitions. Opponents argue ...

The Federal Trade Commission (FTC) is probing whether John Deere used unfair practices related to the repair of its agricultural equipment that might violate the FTC Act. The investigation into ...

A dozen consumer groups and trade unions on Thursday penned a letter (PDF) to Lina Khan, chair of the U.S. Federal Trade Commission (FTC), urging ... patient access to drugs, not only for GLP ...

It is no secret that the Federal Trade Commission (FTC) under Chair Lina Khan has an expansive enforcement agenda and has brought previously unthinkable antitrust charges against Big Tech firms.

and others expressed concerns in a letter to the FTC about the $16.5 billion deal, which Novo Holdings has said would boost supply of Wegovy, Novo's blockbuster GLP-1 injectable weight-loss drug.

The Federal Trade Commission (FTC) finally released its long-awaited Negative Option Rule (the Final Rule), aka the “Click-to-Cancel Rule,” on October 16. The Final Rule was approved by a ...